Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study

Background Antituberculosis drugs show good efficacy but have adverse effects including hepatotoxicity. Objective To find the incidence and characteristics of antituberculosis hepatotoxicity in children during the first 2 weeks of therapy. Methods A cohort study was performed in Cipto Mangunkusu...

Full description

Bibliographic Details
Main Authors:	Bina Akura, Hanifah Oswari, Bambang Supriyatno, Najib Advani
Format:	Article
Language:	English
Published:	Indonesian Pediatric Society Publishing House 2009-12-01
Series:	Paediatrica Indonesiana
Subjects:	antituberculosis hepatotoxicity incidence, characteristics
Online Access:	https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/599

Similar Items

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis
by: Vycke Yunivita, et al.
Published: (2019-10-01)

Risk Factors of Antituberculosis Induced-Hepatotoxicity among HIV/AIDS Patients
by: Lies Luthariana, et al.
Published: (2017-03-01)

Incidence and Clinical Profile of Antituberculosis Treatment-Induced Hepatitis in a Tertiary Care Hospital in Southern India
by: TP Jai Juganya, et al.
Published: (2020-10-01)

GC/MS Analysis and Protective Effects of <i>Mentha longifolia</i> L. Essential Oil Against Antituberculosis Drug-Induced Organs Toxicity in Wistar Albino Rats
by: Usama K. Abdel-Hameed, et al.
Published: (2024-11-01)

Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
by: Vera Dianwari, et al.
Published: (2017-12-01)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016-09-01)

Incidence of side effects of antituberculosis drugs and their related factors in northern Iran: a retrospective cohort study
by: Kheradmand, Motahareh, et al.
Published: (2024-05-01)

Structure of Comorbidity of the Hepatobiliary System in Newly Diagnosed Pulmonary Tuberculosis Depending on Sensitivity Spectrum
by: L.D. Todoriko, et al.
Published: (2015-11-01)

Hyperuricemia, use of antituberculosis drugs, and liver injury: case report
by: Vina Yuwantari, et al.
Published: (2023-08-01)

Acute toxicity of pyridoxine hydrochloride-containing and noncontaining antituberculosis drugs (an experimental study)
by: K. I. Usov, et al.
Published: (2014-12-01)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
by: Moreea Loukman, et al.
Published: (2023-01-01)

Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges
by: Monica Meloni, et al.
Published: (2015-12-01)

Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations
by: Gozde Koycu Buhari, MD, et al.
Published: (2024-01-01)

Unsuccessful antituberculosis medication treatment: A characteristic summarization in a suburban province with dense communities of Myanmar migrant worker in Bangkok Metropolitan Region, Thailand
by: Rujittika Mungmunpuntipantip, et al.
Published: (2019-01-01)

Uric acid levels in patients on antituberculosis drugs in the southwest Region of Cameroon
by: Benjamin David Thumamo Pokam, et al.
Published: (2018-01-01)

CYP2E1-DEPENDENT VARIATIONS IN HEPATOCYTES DAMAGE DURING TREATMENT OF TUBERCULOSIS
by: L.V. Natrus, et al.
Published: (2020-09-01)

Dynamics of the incidence of the relapses in patients with pulmonary tuberculosis
by: V.M. Melnyk, et al.
Published: (2021-09-01)

Mechanism of hepatoprotective action of methionine and composition “Metovitan” against a background of antituberculosis drugs administration to rats
by: S. I. Anisimova, et al.
Published: (2013-04-01)

Uric acid levels in patients on antituberculosis drugs in the Southwest region of Cameroon
by: Benjamin D. Thumamo Pokam, et al.
Published: (2016-01-01)

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
by: Prso K, et al.
Published: (2020-08-01)

HLA-DQ B1*0201 and A1*0102 alleles are not responsible of antituberculosis drugs induced hepatotoxicity risk in Spanish population
by: VIRGINIA LEIRO-FERNÁNDEZ, et al.
Published: (2016-08-01)

Development of real-time pcr technology for the rapid detection of mycobacterium tuberculosis resistance to reserve antituberculosis drugs: fluoroquinolones, amikacin, and capreomycin
by: Yu. S. Alyapkina, et al.
Published: (2014-12-01)

Propolis modulates cellular biochemistry, antioxidants, cytokine profile, histological and ultra-morphological status against antituberculosis drugs induced hepatic injury
by: Nisha Sahu, et al.
Published: (2018-01-01)

Role of Drug Metabolic Enzymes and Transporters in Drug-Drug Interactions Between Antiretroviral and Antituberculosis Drugs
by: Md Masud Parvez, et al.
Published: (2018-04-01)

RETRACTED: Safety Evaluation of Antituberculosis Drugs During Pregnancy: A Systematic Review and Meta-Analysis
by: Xiaomei Zhou, et al.
Published: (2022-04-01)

Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity Hepatotoxicidade induzida pelos tuberculostáticos: comparação em pacientes com e sem soropositividade para o vírus da imunodeficiência humana
by: Natalia Saldanha Magalhães Coca, et al.
Published: (2010-12-01)

Synthesis, structural studies and antituberculosis evaluation of new hydrazone derivatives of quinoline and their Zn(II) complexes
by: Mustapha C. Mandewale, et al.
Published: (2018-02-01)

NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
by: Luis Jaramillo‐Valverde, et al.
Published: (2022-08-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: A randomized, comparative study
by: Ahmad Farooq Alsayed Hasanain, et al.
Published: (2017-01-01)

Experimental and theoretical studies on antituberculosis activity of different benzimidazole derivatives
by: Suna Kızılyıldırım, et al.
Published: (2025-02-01)

Tuberculous ulcer of tongue with oral complications of oral antituberculosis therapy
by: Ajay G, et al.
Published: (2006-01-01)

Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury
by: Wanvisa Udomsinprasert, et al.
Published: (2022-09-01)

In vitro optimization of crushed drug-sensitive antituberculosis medication when administered via a nasogastric tube
by: Cassius M. Phogole, et al.
Published: (2024-01-01)

Protein kinases as antituberculosis targets: The case of thymidylate kinases
by: Sudarkodi Sukumar, et al.
Published: (2020-03-01)

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates
by: Prabasiwi Nur Fauziyah, et al.
Published: (2017-03-01)

Antituberculosis Properties of Methyldioxotetrahydropyrimidine Sulfonisonicotinoyl Hydrazide
by: B. S. Kibrik, et al.
Published: (2020-05-01)

Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury
by: D S Sukhanov
Published: (2012-11-01)

Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review
by: Chia-Hao Chang, et al.
Published: (2023-02-01)

Case Report: DRESS Syndrome Induced by Two Antituberculosis Drugs in an 8-Year-Old Girl
by: Vaidotas Urbonas, et al.
Published: (2022-02-01)